These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10861433)

  • 21. High and intermediate grade ductal carcinoma in-situ of the breast: a comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close or positive margin in the excision.
    Fadare O; Clement NF; Ghofrani M
    Diagn Pathol; 2009 Aug; 4():26. PubMed ID: 19691836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
    Vicini FA; Kestin LL; Goldstein NS
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):722-30. PubMed ID: 15465188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
    Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy.
    Vicini FA; Goldstein NS; Pass H; Kestin LL
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):86-94. PubMed ID: 15337543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.
    Ringberg A; Idvall I; Fernö M; Anderson H; Anagnostaki L; Boiesen P; Bondesson L; Holm E; Johansson S; Lindholm K; Ljungberg O; Ostberg G
    Eur J Surg Oncol; 2000 Aug; 26(5):444-51. PubMed ID: 11016463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histological margin assessment for breast ductal carcinoma in situ: precision and implications.
    Sigal-Zafrani B; Lewis JS; Clough KB; Vincent-Salomon A; Fourquet A; Meunier M; Falcou MC; Sastre-Garau X;
    Mod Pathol; 2004 Jan; 17(1):81-8. PubMed ID: 14657957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy.
    Rudloff U; Brogi E; Reiner AS; Goldberg JI; Brockway JP; Wynveen CA; McCormick B; Patil S; Van Zee KJ
    Ann Surg; 2010 Apr; 251(4):583-91. PubMed ID: 20224381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Vicini FA; Shaitelman S; Wilkinson JB; Shah C; Ye H; Kestin LL; Goldstein NS; Chen PY; Martinez AA
    Breast J; 2013; 19(4):365-73. PubMed ID: 23815268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
    Kerlikowske K; Molinaro A; Cha I; Ljung BM; Ernster VL; Stewart K; Chew K; Moore DH; Waldman F
    J Natl Cancer Inst; 2003 Nov; 95(22):1692-702. PubMed ID: 14625260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ductal carcinoma in situ: size and resection volume predict margin status.
    Melstrom LG; Melstrom KA; Wang EC; Pilewskie M; Winchester DJ
    Am J Clin Oncol; 2010 Oct; 33(5):438-42. PubMed ID: 20023569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone.
    Schwartz GF; Finkel GC; Garcia JC; Patchefsky AS
    Cancer; 1992 Nov; 70(10):2468-74. PubMed ID: 1330281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of specimen radiography in patients treated with skin-sparing mastectomy for ductal carcinoma in situ of the breast.
    Rubio IT; Mirza N; Sahin AA; Whitman G; Kroll SS; Ames FC; Singletary SE
    Ann Surg Oncol; 2000 Aug; 7(7):544-8. PubMed ID: 10947024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Rudloff U; Brogi E; Brockway JP; Goldberg JI; Cranor M; Wynveen CA; Nehhozina T; Reiner AS; Patil S; Van Zee KJ
    Cancer; 2009 Mar; 115(6):1203-14. PubMed ID: 19170233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature.
    Vicini FA; Recht A
    J Clin Oncol; 2002 Jun; 20(11):2736-44. PubMed ID: 12039936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
    Hetelekidis S; Collins L; Silver B; Manola J; Gelman R; Cooper A; Lester S; Lyons JA; Harris JR; Schnitt SJ
    Cancer; 1999 Jan; 85(2):427-31. PubMed ID: 10023711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy: implications for optimal follow-up strategies.
    Shaitelman SF; Wilkinson JB; Kestin LL; Ye H; Goldstein NS; Martinez AA; Vicini FA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e305-12. PubMed ID: 22417804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS.
    Fisher CS; Klimberg VS; Khan S; Gao F; Margenthaler JA
    Ann Surg Oncol; 2011 Oct; 18(11):3155-9. PubMed ID: 21947593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Location and extent of positive resection margins and ductal carcinoma in situ in lumpectomy specimens of ductal breast carcinoma examined with a microscopic three-dimensional view.
    Mai KT; Perkins DG; Mirsky D
    Breast J; 2003; 9(1):33-8. PubMed ID: 12558668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements.
    Faverly DR; Hendriks JH; Holland R
    Cancer; 2001 Feb; 91(4):647-59. PubMed ID: 11241230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.